U.K. retailer The Co-operative Group announced plans to manufacture its own line of drugs at a new factory in China. The plan involves a joint venture with Tasly Group, one of China's largest producers of herbal medicines, and is seen as a way to give the retailer greater control over its supply chain.

Related Summaries